387 related articles for article (PubMed ID: 26253278)
1. mTOR and its tight regulation for iNKT cell development and effector function.
Yang W; Gorentla B; Zhong XP; Shin J
Mol Immunol; 2015 Dec; 68(2 Pt C):536-45. PubMed ID: 26253278
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
[TBL] [Abstract][Full Text] [Related]
3. mTORC2 regulates multiple aspects of NKT-cell development and function.
Sklarz T; Guan P; Gohil M; Cotton RM; Ge MQ; Haczku A; Das R; Jordan MS
Eur J Immunol; 2017 Mar; 47(3):516-526. PubMed ID: 28078715
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.
Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH
J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366
[TBL] [Abstract][Full Text] [Related]
5. iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions.
Wu J; Yang J; Yang K; Wang H; Gorentla B; Shin J; Qiu Y; Que LG; Foster WM; Xia Z; Chi H; Zhong XP
J Clin Invest; 2014 Apr; 124(4):1685-98. PubMed ID: 24614103
[TBL] [Abstract][Full Text] [Related]
6. β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation.
Berga-Bolaños R; Sharma A; Steinke FC; Pyaram K; Kim YH; Sultana DA; Fang JX; Chang CH; Xue HH; Heller NM; Sen JM
BMC Immunol; 2015 Oct; 16():62. PubMed ID: 26482437
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.
Uddin MN; Sultana DA; Lorentsen KJ; Cho JJ; Kirst ME; Brantly ML; Califano D; Sant'Angelo DB; Avram D
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7608-13. PubMed ID: 27330109
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision.
Wei J; Yang K; Chi H
J Immunol; 2014 Nov; 193(9):4297-4301. PubMed ID: 25261481
[TBL] [Abstract][Full Text] [Related]
9. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ
J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486
[TBL] [Abstract][Full Text] [Related]
10. The Protein Phosphatase Shp1 Regulates Invariant NKT Cell Effector Differentiation Independently of TCR and Slam Signaling.
Cruz Tleugabulova M; Zhao M; Lau I; Kuypers M; Wirianto C; Umaña JM; Lin Q; Kronenberg M; Mallevaey T
J Immunol; 2019 Apr; 202(8):2276-2286. PubMed ID: 30796181
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function.
Shin J; Wang S; Deng W; Wu J; Gao J; Zhong XP
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):E776-83. PubMed ID: 24516149
[TBL] [Abstract][Full Text] [Related]
12. Uhrf1 Controls iNKT Cell Survival and Differentiation through the Akt-mTOR Axis.
Cui Y; Chen X; Zhang J; Sun X; Liu H; Bai L; Xu C; Liu X
Cell Rep; 2016 Apr; 15(2):256-63. PubMed ID: 27050515
[TBL] [Abstract][Full Text] [Related]
13. Critical roles of RasGRP1 for invariant NKT cell development.
Shen S; Chen Y; Gorentla BK; Lu J; Stone JC; Zhong XP
J Immunol; 2011 Nov; 187(9):4467-73. PubMed ID: 21957144
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cell development: focus on NOD mice.
Ghazarian L; Simoni Y; Magalhaes I; Lehuen A
Curr Opin Immunol; 2014 Apr; 27():83-8. PubMed ID: 24637104
[TBL] [Abstract][Full Text] [Related]
15. Applying the TOR(C)QUE in iNKT cells: A new twist in an old tale.
Verykokakis M; Kee BL
Eur J Immunol; 2017 Mar; 47(3):454-457. PubMed ID: 28295259
[TBL] [Abstract][Full Text] [Related]
16. The role and regulation of mTOR in T-lymphocyte function.
O'Brien TF; Zhong XP
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):173-81. PubMed ID: 22484804
[TBL] [Abstract][Full Text] [Related]
17. iNKT subsets differ in their developmental and functional requirements on Foxo1.
Zhang H; Zhang Y; Pan J; Wu Q; Huang Y; Bai S; Tian C; Zhu M; Lian Z; Li F; Tian Z; Bai L
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34772808
[TBL] [Abstract][Full Text] [Related]
18. Tight regulation of diacylglycerol-mediated signaling is critical for proper invariant NKT cell development.
Shen S; Wu J; Srivatsan S; Gorentla BK; Shin J; Xu L; Zhong XP
J Immunol; 2011 Sep; 187(5):2122-9. PubMed ID: 21775687
[TBL] [Abstract][Full Text] [Related]
19. Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation.
Pei B; Zhao M; Miller BC; Véla JL; Bruinsma MW; Virgin HW; Kronenberg M
J Immunol; 2015 Jun; 194(12):5872-84. PubMed ID: 25926673
[TBL] [Abstract][Full Text] [Related]
20. TCR signal strength controls thymic differentiation of iNKT cell subsets.
Tuttle KD; Krovi SH; Zhang J; Bedel R; Harmacek L; Peterson LK; Dragone LL; Lefferts A; Halluszczak C; Riemondy K; Hesselberth JR; Rao A; O'Connor BP; Marrack P; Scott-Browne J; Gapin L
Nat Commun; 2018 Jul; 9(1):2650. PubMed ID: 29985393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
